@article {1635656,
	title = {Effects of Subcutaneous Repository Corticotropin Gel Injection on Regulatory T Cell Population in Noninfectious Retinal Vasculitis},
	journal = {Ocul Immunol Inflamm},
	volume = {31},
	number = {3},
	year = {2023},
	month = {2023 Apr},
	pages = {556-565},
	abstract = {AIM: To evaluate the effect of repository corticotropin injection (RCI) on regulatory T cell population in patients with noninfectious retinal vasculitis. PATIENTS AND METHODS: Patients with active noninfectious retinal vasculitis were included in a prospective nonrandomized open-label study. RESULTS: Eighteen patients (33 eyes) were included in the study. Eleven (61.1\%) patients [20 (60.6\%) eyes] and 7 (38.9\%) patients [13 (33.3\%) eyes] were in the responsive and non-responsive groups, respectively. We did not find any statistically significant difference within the PPP-R group, within the PPP-NR group, or between these two groups in regard to regulatory T cell population. No significant systemic or ocular complications were found. CONCLUSION: RCI may be a complementary treatment in patients with non-infectious retinal vasculitis with or without uveitis. This study did not demonstrate an increase in regulatory T cell population in patients with noninfectious retinal vasculitis.},
	keywords = {Adrenocorticotropic Hormone, Humans, Prospective Studies, Retinal Vasculitis, T-Lymphocytes, Regulatory, Uveitis},
	issn = {1744-5078},
	doi = {10.1080/09273948.2022.2042323},
	author = {Anesi, Stephen D and Chang, Peter Y and Maleki, Arash and Manhapra, Ambika and Look-Why, Sydney and Asgari, Soheila and Walsh, Marisa and Drenen, Kayla and Foster, C Stephen}
}
